Shanghai Sorrento Medical Technology Co., Ltd is a high-tech company founded by Sorrento Therapeutics, Inc. (Nasdaq: SRNE), located in Xiangyun Science Park, Jiading District, Shanghai. We focus on the research, design, manufacture, and sale of hyperthermia systems that treat cancer effectively and non-invasively. Our R&D team in Sorrento Therapeutics - Shanghai Jiao Tong University Joint Research Center possess talented postdocs and PhDs who share a common goal - to improve oncological treatments from both the study of mechanisms of biophysical therapy and the development of modern hyperthermia systems, providing a close integration platform for international medical advancements while meeting domestic market demands.

Shanghai Sorrento Medical Technology Co., Ltd works closely with the U.S. National Cancer Institute, Shanghai Jiao Tong University, Tsinghua University, and Sorrento Therapeutics, Inc. in the United States. We possess unique physical-targeted and bio-targeted tumor treatment technologies.